<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>21</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>11</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Frequency of Anti-Toxoplasma gondii IgM and IgG and the Associ-ated Risk Factors in Patients with Breast Cancer: A Case-Control Study</title>
    <FirstPage>488</FirstPage>
    <LastPage>497</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Ebrahimi</LastName>
        <affiliation locale="en_US">Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Eisa</FirstName>
        <LastName>Nazar</LastName>
        <affiliation locale="en_US">Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Rostami</LastName>
        <affiliation locale="en_US">Health Research Institute, Infectious Diseases and Tropical Medicine Research Centre, Babol University of Medical Sciences, Babol, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Mirjalali</LastName>
        <affiliation locale="en_US">Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arian</FirstName>
        <LastName>Taghdiri</LastName>
        <affiliation locale="en_US">Student Research Committee, Gonabad University of Medical Sciences, Gonabad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Pazoki</LastName>
        <affiliation locale="en_US">Department of Medical Microbiology, Infectious Diseases Research Center, Faculty of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>10</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Toxoplasma gondii is an obligate intracellular parasite capable of causing serious disease, especially among individuals with compromised immunity, including those undergoing cancer treatment. Approximately one-third of the global population is infected with. gondii. The present investigation evaluated the prevalence of anti-T. gondii IgM and IgG antibodies and explored related risk factors in breast cancer patients compared with healthy controls.
Methods: Between Oct 2023 and Feb 2024, serum samples were obtained from 167 women, including 111 with breast cancer and 56 healthy controls. Anti-T. gondii IgM and IgG antibodies were measured through ELISA. Structured questionnaires were employed to record demographic profiles and relevant exposure factors. Data were statistically processed using chi-square, t-test, and logistic regression modeling.
Results: Overall, the IgG antibody was positive in 48.6% of the cases with breast cancer and 33.9% of the control group. However, the groups had similar mean T. gondii IgG antibody titers, with no significant differences. Moreover, the IgM antibody tests were negative in both groups. Our results show a high seropositivity rate for toxoplasmosis in age groups over 50 yr old. No meaningful correlations were identified between seropositivity and other factors such as dietary habits, contact with animals, or history of blood transfusion.
Conclusion: Anti-T. gondii IgG seropositivity was higher among breast cancer patients than controls, but the association was not statistically significant after adjustment for potential confounders. These findings do not provide sufficient evidence of an association between T. gondii seropositivity and breast cancer. Further studies with larger sample sizes are warranted to clarify this relationship.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/4749</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/4749/1530</pdf_url>
  </Article>
</Articles>
